Table 1:

The [⁷⁷Br]RD1 pharmacological parameters calculated from total and nonspecific binding studies in the various ovarian cancer cell lines and their corresponding 95% CI.

Ovarian Cancer Cell Line	${\text{B}}_{\text{max}}$ (95% CI) (attomol/cell)	${\text{K}}_{\text{d}}$(95% CI) (nM)	NS (95% CI) (attomol/cell/nM)
ID8	3.0 (2.4–3.9)	31 (20–49)	0.049 (0.047–0.052)
OVCAR8	1.6 (1.4–1.8)	6.0 (4.2–8.2)	0.050 (0.048–0.052)
OVCAR8 PARP1-KO	0.83 (0.50–1.5)	7.5 (2.7–20)	0.039 (0.033–0.046)
UWB1.289	11 (7.9–16)	24 (10–57)	0.20 (0.19–0.21)
UWB1.289+BRCA1	8.6 (6.6–11)	25 (13–48)	0.26 (0.25–0.26)